Genetically designed biosensing systems for high-throughput screening of pharmaceuticals, clinical diagnostics, and environmental monitoring

B. R. Wenner, P. M. Douglass, S. Shrestha, B. V. Sharma, S. Lai, M. J. Madou, Sylvia Daunert

Research output: Chapter in Book/Report/Conference proceedingConference contribution

5 Citations (Scopus)

Abstract

The genetically-modified binding proteins calmodulin (CaM), the phosphate binding protein (PBP), the sulfate binding protein (SBP), and the galactose/glucose binding protein (GBP) have been successfully employed as biosensing elements for the detection of phenothiazines, phosphate, sulfate, and glucose, respectively. Mutant proteins containing unique cysteine residues were utilized in the site-specific labeling of environment-sensitive fluorescent probes. Changes in the environment of the probes upon ligand-induced conformational changes of the proteins result in changes in fluorescence intensity. Calibration plots for the respective analytes were generated that relate the concentration of analyte with a change in fluorescence intensity of the biosensing element. The assays were also characterized in terms of their selectivity and the stability of the binding protein. To illustrate the usefulness of the reagents in high-throughput analyses for application in drug discovery, point-of-care diagnostics, and environmental monitoring, the assays were evaluated on a novel system-the CD platform. This microfluidic compact disc-based platform utilizes centrifugal force to control the release, flow, and mixing of buffers, reagents, and analytes in channels and reservoirs contained on the microfabricated CD. Coupling of fluorescence detection on this system with the genetically designed reagents provides highly sensitive assays for microscale applications. Specifically, the labeled proteins were shown to be sensitive to increasing concentrations of analyte in mL, μL, nL, and pL volume samples, with limits of detection in the sub-micromolar range. In addition, sol-gel composites have been investigated as a means of entrapping the aforementioned biorecognition elements for the purpose of immobilizing the proteins on a sensing platform such as the CD. The advantages of the CD platform and its application in drug discovery and diagnostics will be discussed, along with preliminary experiments showing the response of PBP in sol-gel composites.

Original languageEnglish (US)
Title of host publicationProceedings of SPIE - The International Society for Optical Engineering
EditorsJ.R. Lakowicz, R.B. Thompson
Pages59-70
Number of pages12
Volume4252
DOIs
StatePublished - 2001
Externally publishedYes
EventAdvances in Flourescence Sensing Technology V - San Jose, CA, United States
Duration: Jan 24 2001Jan 25 2001

Other

OtherAdvances in Flourescence Sensing Technology V
CountryUnited States
CitySan Jose, CA
Period1/24/011/25/01

Fingerprint

environmental monitoring
Drug products
Screening
screening
Throughput
proteins
Monitoring
Proteins
Assays
Phosphates
Fluorescence
platforms
Sol-gels
Glucose
reagents
Calmodulin
phosphates
glucose
fluorescence
Composite materials

Keywords

  • Calmodulin (CaM)
  • Compact disc (CD)
  • Fluorescence
  • Galactose binding protein
  • Glucose binding protein (GBP)
  • Microfluidics
  • Optical sensing
  • Phosphate binding protein (PBP)
  • Site-directed mutagenesis
  • Sol-gel
  • Sulfate binding protein (SBP)

ASJC Scopus subject areas

  • Electrical and Electronic Engineering
  • Condensed Matter Physics

Cite this

Wenner, B. R., Douglass, P. M., Shrestha, S., Sharma, B. V., Lai, S., Madou, M. J., & Daunert, S. (2001). Genetically designed biosensing systems for high-throughput screening of pharmaceuticals, clinical diagnostics, and environmental monitoring. In J. R. Lakowicz, & R. B. Thompson (Eds.), Proceedings of SPIE - The International Society for Optical Engineering (Vol. 4252, pp. 59-70) https://doi.org/10.1117/12.426736

Genetically designed biosensing systems for high-throughput screening of pharmaceuticals, clinical diagnostics, and environmental monitoring. / Wenner, B. R.; Douglass, P. M.; Shrestha, S.; Sharma, B. V.; Lai, S.; Madou, M. J.; Daunert, Sylvia.

Proceedings of SPIE - The International Society for Optical Engineering. ed. / J.R. Lakowicz; R.B. Thompson. Vol. 4252 2001. p. 59-70.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Wenner, BR, Douglass, PM, Shrestha, S, Sharma, BV, Lai, S, Madou, MJ & Daunert, S 2001, Genetically designed biosensing systems for high-throughput screening of pharmaceuticals, clinical diagnostics, and environmental monitoring. in JR Lakowicz & RB Thompson (eds), Proceedings of SPIE - The International Society for Optical Engineering. vol. 4252, pp. 59-70, Advances in Flourescence Sensing Technology V, San Jose, CA, United States, 1/24/01. https://doi.org/10.1117/12.426736
Wenner BR, Douglass PM, Shrestha S, Sharma BV, Lai S, Madou MJ et al. Genetically designed biosensing systems for high-throughput screening of pharmaceuticals, clinical diagnostics, and environmental monitoring. In Lakowicz JR, Thompson RB, editors, Proceedings of SPIE - The International Society for Optical Engineering. Vol. 4252. 2001. p. 59-70 https://doi.org/10.1117/12.426736
Wenner, B. R. ; Douglass, P. M. ; Shrestha, S. ; Sharma, B. V. ; Lai, S. ; Madou, M. J. ; Daunert, Sylvia. / Genetically designed biosensing systems for high-throughput screening of pharmaceuticals, clinical diagnostics, and environmental monitoring. Proceedings of SPIE - The International Society for Optical Engineering. editor / J.R. Lakowicz ; R.B. Thompson. Vol. 4252 2001. pp. 59-70
@inproceedings{55a3a17d776e463dad437f695c5dc07b,
title = "Genetically designed biosensing systems for high-throughput screening of pharmaceuticals, clinical diagnostics, and environmental monitoring",
abstract = "The genetically-modified binding proteins calmodulin (CaM), the phosphate binding protein (PBP), the sulfate binding protein (SBP), and the galactose/glucose binding protein (GBP) have been successfully employed as biosensing elements for the detection of phenothiazines, phosphate, sulfate, and glucose, respectively. Mutant proteins containing unique cysteine residues were utilized in the site-specific labeling of environment-sensitive fluorescent probes. Changes in the environment of the probes upon ligand-induced conformational changes of the proteins result in changes in fluorescence intensity. Calibration plots for the respective analytes were generated that relate the concentration of analyte with a change in fluorescence intensity of the biosensing element. The assays were also characterized in terms of their selectivity and the stability of the binding protein. To illustrate the usefulness of the reagents in high-throughput analyses for application in drug discovery, point-of-care diagnostics, and environmental monitoring, the assays were evaluated on a novel system-the CD platform. This microfluidic compact disc-based platform utilizes centrifugal force to control the release, flow, and mixing of buffers, reagents, and analytes in channels and reservoirs contained on the microfabricated CD. Coupling of fluorescence detection on this system with the genetically designed reagents provides highly sensitive assays for microscale applications. Specifically, the labeled proteins were shown to be sensitive to increasing concentrations of analyte in mL, μL, nL, and pL volume samples, with limits of detection in the sub-micromolar range. In addition, sol-gel composites have been investigated as a means of entrapping the aforementioned biorecognition elements for the purpose of immobilizing the proteins on a sensing platform such as the CD. The advantages of the CD platform and its application in drug discovery and diagnostics will be discussed, along with preliminary experiments showing the response of PBP in sol-gel composites.",
keywords = "Calmodulin (CaM), Compact disc (CD), Fluorescence, Galactose binding protein, Glucose binding protein (GBP), Microfluidics, Optical sensing, Phosphate binding protein (PBP), Site-directed mutagenesis, Sol-gel, Sulfate binding protein (SBP)",
author = "Wenner, {B. R.} and Douglass, {P. M.} and S. Shrestha and Sharma, {B. V.} and S. Lai and Madou, {M. J.} and Sylvia Daunert",
year = "2001",
doi = "10.1117/12.426736",
language = "English (US)",
volume = "4252",
pages = "59--70",
editor = "J.R. Lakowicz and R.B. Thompson",
booktitle = "Proceedings of SPIE - The International Society for Optical Engineering",

}

TY - GEN

T1 - Genetically designed biosensing systems for high-throughput screening of pharmaceuticals, clinical diagnostics, and environmental monitoring

AU - Wenner, B. R.

AU - Douglass, P. M.

AU - Shrestha, S.

AU - Sharma, B. V.

AU - Lai, S.

AU - Madou, M. J.

AU - Daunert, Sylvia

PY - 2001

Y1 - 2001

N2 - The genetically-modified binding proteins calmodulin (CaM), the phosphate binding protein (PBP), the sulfate binding protein (SBP), and the galactose/glucose binding protein (GBP) have been successfully employed as biosensing elements for the detection of phenothiazines, phosphate, sulfate, and glucose, respectively. Mutant proteins containing unique cysteine residues were utilized in the site-specific labeling of environment-sensitive fluorescent probes. Changes in the environment of the probes upon ligand-induced conformational changes of the proteins result in changes in fluorescence intensity. Calibration plots for the respective analytes were generated that relate the concentration of analyte with a change in fluorescence intensity of the biosensing element. The assays were also characterized in terms of their selectivity and the stability of the binding protein. To illustrate the usefulness of the reagents in high-throughput analyses for application in drug discovery, point-of-care diagnostics, and environmental monitoring, the assays were evaluated on a novel system-the CD platform. This microfluidic compact disc-based platform utilizes centrifugal force to control the release, flow, and mixing of buffers, reagents, and analytes in channels and reservoirs contained on the microfabricated CD. Coupling of fluorescence detection on this system with the genetically designed reagents provides highly sensitive assays for microscale applications. Specifically, the labeled proteins were shown to be sensitive to increasing concentrations of analyte in mL, μL, nL, and pL volume samples, with limits of detection in the sub-micromolar range. In addition, sol-gel composites have been investigated as a means of entrapping the aforementioned biorecognition elements for the purpose of immobilizing the proteins on a sensing platform such as the CD. The advantages of the CD platform and its application in drug discovery and diagnostics will be discussed, along with preliminary experiments showing the response of PBP in sol-gel composites.

AB - The genetically-modified binding proteins calmodulin (CaM), the phosphate binding protein (PBP), the sulfate binding protein (SBP), and the galactose/glucose binding protein (GBP) have been successfully employed as biosensing elements for the detection of phenothiazines, phosphate, sulfate, and glucose, respectively. Mutant proteins containing unique cysteine residues were utilized in the site-specific labeling of environment-sensitive fluorescent probes. Changes in the environment of the probes upon ligand-induced conformational changes of the proteins result in changes in fluorescence intensity. Calibration plots for the respective analytes were generated that relate the concentration of analyte with a change in fluorescence intensity of the biosensing element. The assays were also characterized in terms of their selectivity and the stability of the binding protein. To illustrate the usefulness of the reagents in high-throughput analyses for application in drug discovery, point-of-care diagnostics, and environmental monitoring, the assays were evaluated on a novel system-the CD platform. This microfluidic compact disc-based platform utilizes centrifugal force to control the release, flow, and mixing of buffers, reagents, and analytes in channels and reservoirs contained on the microfabricated CD. Coupling of fluorescence detection on this system with the genetically designed reagents provides highly sensitive assays for microscale applications. Specifically, the labeled proteins were shown to be sensitive to increasing concentrations of analyte in mL, μL, nL, and pL volume samples, with limits of detection in the sub-micromolar range. In addition, sol-gel composites have been investigated as a means of entrapping the aforementioned biorecognition elements for the purpose of immobilizing the proteins on a sensing platform such as the CD. The advantages of the CD platform and its application in drug discovery and diagnostics will be discussed, along with preliminary experiments showing the response of PBP in sol-gel composites.

KW - Calmodulin (CaM)

KW - Compact disc (CD)

KW - Fluorescence

KW - Galactose binding protein

KW - Glucose binding protein (GBP)

KW - Microfluidics

KW - Optical sensing

KW - Phosphate binding protein (PBP)

KW - Site-directed mutagenesis

KW - Sol-gel

KW - Sulfate binding protein (SBP)

UR - http://www.scopus.com/inward/record.url?scp=0034930441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034930441&partnerID=8YFLogxK

U2 - 10.1117/12.426736

DO - 10.1117/12.426736

M3 - Conference contribution

VL - 4252

SP - 59

EP - 70

BT - Proceedings of SPIE - The International Society for Optical Engineering

A2 - Lakowicz, J.R.

A2 - Thompson, R.B.

ER -